Objective Genetic variation at the type II deiodinase (D2) gene (DIO2) was previously identifi ed as osteoarthritis (OA) risk factor. To investigate mechanisms possibly underlying this association, we assessed D2 protein in healthy and OA-affected cartilage and investigated allelic balance of the OA risk polymorphism rs225014 at DIO2 in human OA joints. Methods Immunohistochemical staining of healthy and OA-affected cartilage was performed for D2. We then assessed allelic balance of DIO2 mRNA within OA-affected cartilage both at and away from the lesion, ligaments and subchondral bone. Allelic balance was measured by the amount of alleles 'C' and 'T' of the intragenic OA risk polymorphism rs225014 in heterozygous carriers. Results A markedly higher amount of D2 positive cells and staining intensity was observed in OA cartilage. A signifi cant, 1.3-fold higher presence was observed for the OA-associated rs225014 'C' allele relative to the 'T' allele of DIO2, which was signifi cant in 28 of 31 donors. Conclusion In OA cartilage, D2 protein presence is increased. The allelic imbalance of the DIO2 mRNA transcript, with the OA risk allele 'C' of rs225014 more abundant than the wild-type 'T' allele in heterozygote carriers provides a possible mechanism by which genetic variation at DIO2 confers OA risk.
INTRODUCTION
Osteoarthritis (OA) is a common degenerative disease of the articulating joints with a considerable, but complex, genetic component. 1 Although many genes with small effect sizes are expected to contribute to OA, recent genetic studies have provided a few consistent signals such as 7q22, GDF5 and type II deiodinase (D2) gene (DIO2) identifi ed by our own group. 2 3 Functional follow-up of association signals is imperative to further elucidate the underlying OA aetiology.
D2 locally activates thyroid signalling in specifi c tissues, including cartilage of the growth plate. 4 The predisposing single nucleotide polymorphism (SNP) at DIO2 is non-synonymous; however, it does not infl uence D2 kinetics. 5 We hypothesised that the polymorphism may mark variation at cis-acting regulatory elements or
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MATERIALS AND METHODS Subjects
We selected hip resection specimens in which degenerative changes were described (OA cartilage, n=11) and hip resections for other reasons (healthy cartilage, n=6) from the Leiden University Medical Center (LUMC) archives. Characteristics of these samples are listed in table 1. For assessment of AI, subjects undergoing hip or knee joint replacement surgery as a result of primary OA were recruited at the Nuffi eld Orthopaedic Centre (Oxford, UK; referred to as 'Nuffi eld' samples, n=7) and at the LUMC (Leiden, The Netherlands; referred to as 'LUMC' samples, n=24). Macroscopically preserved and affected cartilage, the affected area's subchondral bone and hip joint ligaments were sampled and frozen in liquid nitrogen. Ethical approval for the study was obtained from the appropriate ethics committees.
Histological assessment and immunohistochemistry
HE and toluidine blue staining were used to score samples according to Mankin et al 6 by three observers who were blinded to clinicopathological data (JVMGB, IM and SDB). The Mankin scoring ranges from 0 (no OA signs) to 15 (total cartilage destruction) and samples are scored for microscopic OA features. For staining the D2 protein, the custom 7 polyclonal antibody was performed according to standard procedures as previously described by Bovée et al 8 (see also online supplementary methods). Quantifi cation of the D2 staining is described in table 1.
Nucleic acid isolation and rs225014 genotyping
Isolation of samples was according to protocols described earlier 9 (see also online supplementary methods). In short, samples were powdered using .2) 9.5 (2.0) 9 (3.5) †Evaluation of Mankin score and D2 staining was performed by agreement among three reviewers (JVMGB, SDB, IM) who were blinded to the clinical status of the samples. ‡Individual D2 scores were given for cytoplasmic and nucleic staining of chondrocytes in each cartilage layer (superfi cial, middle and deep) with a score 0, 1 and 2 for no staining, moderate staining intensity and strong staining intensity, respectively. The scores are summed with score 0 representing no staining in any cartilage layer and score 12 indicating abundant staining in both cytoplasm and nuclei in all three cartilage layers. D2, type II deiodinase; OA, osteoarthritis.
a Retsch (Vleuten, Netherlands) Mixer Mill 200 with continuous liquid nitrogen cooling. RNA isolation was performed using Qiagen (Venlo, Netherlands) RNAeasy Midi kits, DNA isolation was performed on the wash fl ow-through and cDNA was synthesised using random hexamer primers. Using PCR amplifi cation of the region containing rs225014 and digestion using restriction enzyme RsaI (cutting the wild-type allele), genotypes of candidates for the study were obtained. We included only heterozygous subjects.
Assessment of AI
Procedures to assess AI were described in detail by Wilkins et al 10 (see also online supplementary methods). In short, fl uorescence values of single-base extension (Nuffi eld samples), or an allele-specifi c Taqman assay (C_15819951, Applied Biosystems, Bleiswijk, Netherlands, LUMC samples), were used to quantify the allele ratio in the cDNA samples, and genomic DNA of all heterozygote carriers was used as reference for a 1:1 ratio of alleles. On the log transformed allele ratios we performed a Mann-Whitney nonparametric test (SPSS V.16.0) against all genomic DNA samples and a Bonferroni correction was applied to correct for the multiple comparisons (n=31) made.
RESULTS

Immunohistological assessment of D2 in healthy and OA cartilage
Mankin scores were, in general, higher across samples documented with OA as compared with healthy samples although some heterogeneity existed (table 1, figure 1A) . Despite this heterogeneity, we observed little superficial to no D2 staining for healthy cartilage samples, whereas in the OA cartilage samples a general increase of positive cells and staining intensity was observed throughout all layers of the cartilage (table 1, figure 1B-D) . Furthermore, a propensity of higher D2 staining with higher Mankin scores was observed (table 1, figure 1E ). The increased D2 presence in OA samples enables the assessment of mRNA AI of DIO2 in OA joint cartilage. Table 2 shows characteristics of the heterozygous DIO2 rs225014 cartilage samples from Nuffi eld and LUMC and the relative ratios of the 'T' and 'C' alleles for rs225014 for each cDNA sample, with the pooled genomic DNA ratios serving as the 1:1 allelic reference. Figure 2 shows the individual measurements of the genomic and cDNA AI. Six of the seven 
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DISCUSSION
We showed a marked upregulation of D2 protein in cartilage obtained from OA-affected joints as compared with healthy joints, which is in accordance with previous observations of overall DIO2 mRNA expression. 11 12 The observed heterogeneity in the positive correlation between D2 staining, OA status and Mankin scores (table 1, fi gure 1) may represent misclassifi cation of OA status, the sampling of less affected cartilage areas during archiving or innate variation in D2 presence in cartilage with age or OA.
Next, we assessed the amount of DIO2 gene transcript per allele of the OA susceptibility SNP rs2251014. We demonstrate that AI of DIO2 is highly signifi cant and consistent with the OA risk allele 'C' being approximately 1.3 times more abundantly present than the wild-type allele 'T'. This may arise through differences in the stability of the DIO2 mRNA or differences in the transcription rate of the alleles, for example, due to variation in binding potential of relevant transcription factors at cis-regulatory elements. The consistency of the AI indicates that either the polymorphism itself or a polymorphism in strong linkage disequilibrium (LD) is causing the effect. Interestingly, the DIO2 susceptibility SNP lies close to a predicted binding site for a modulator of chromatin variation (CCCTC-binding factor site), which is shown to modulate allele-specifi c variation of expression 13 ; however, these suggestions need further investigation. Nuffi eld samples demonstrated abundance of mRNA containing the rs225014 'C' allele and this was signifi cant (p≤0.01) in four of these six samples after Bonferroni correction. In an overall analysis of all seven Nuffi eld samples, allele 'C' was signifi cantly more abundantly present in the cDNA samples (p<0.01). All 24 LUMC samples demonstrated a signifi cantly higher abundance of the 'C' allele after Bonferroni correction. In an overall analysis of all 24 LUMC samples, allele 'C' was signifi cantly more abundantly present in the cDNA samples (p<0.01). The mean ratio of abundance for the 'C' allele was 1.17 and 1.35 for the Nuffi eld and LUMC samples, respectively. The AI was consistent between hip and knee joints and the two genders. None of the tested genomic DNA samples showed signifi cant deviations from AI when tested against the remaining genomic DNA samples (data not shown).
To investigate whether the destructive process associated with OA infl uenced the presence of the AI, we also performed measurements on cDNA obtained from the preserved areas of cartilage of the same joint for seven donor joints, which resulted in similar AI measurements (online supplementary fi gure 1). To investigate the AI uniformity, we performed similar measurements for rs225014 alleles on cDNA obtained from the ligamentum teres femoris and subchondral bone (n=5 and n=2, respectively), for which we also observed a consistent AI within the same magnitude (online supplementary fi gure 1). The fact that we observed DIO2 AI in various joint tissues (online supplementary fi gure 1) indicates that the AI reaches beyond the degraded cartilage area and might be a ubiquitous phenomenon in joint tissue. Prolonged exposure to higher basal levels of D2 as a result of higher transcription potential of this polymorphism may be considered detrimental to healthy cartilage by driving the chondrocytes towards an unfavourable terminal differentiation through hypertrophy similar to thyroidmediated processes in the growth plate. 4 These observations underline that locally imbalanced allelic and/or altered gene expression may be an important molecular mechanism underlying the genetic predisposition of complex traits in general and OA in particular. 13 The fact that in The Netherlands' LUMC study all samples showed signifi cant AI, whereas in the UK Nuffi eld study only four of seven samples showed signifi cant AI, might be ascribed to the more sensitive technique used in the LUMC study. The technique used in the Nuffi eld samples may account for the higher noise and lower mean AI for these. It is reassuring to note, however, that the use of two different techniques to measure AI both highlighted relative abundance of the 'C' allele of rs225014. Since both studies comprised an analysis of Caucasian individuals from northern Europe, it is unlikely that genetic differences would account for the fact that not all of the UK samples demonstrated AI.
In summary, we showed that in OA cartilage the D2 protein is more abundant and we assessed an AI in the DIO2 mRNA as measured by the intragenic OA susceptibility SNP rs225014 in OA-affected cartilage; the OA risk allele had more RNA transcript in joint tissues of heterozygous donors. It is compelling to hypothesise that such a subtle difference throughout life may be detrimental to the articular cartilage and underlies OA disease onset and progression.
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